90 related articles for article (PubMed ID: 7889200)
1. Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury.
Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Horiuchi M; Katori R
Blood Press Suppl; 1994; 5():43-8. PubMed ID: 7889200
[TBL] [Abstract][Full Text] [Related]
2. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.
Kawamura M; Terashita Z; Okuda H; Imura Y; Shino A; Nakao M; Nishikawa K
J Pharmacol Exp Ther; 1993 Sep; 266(3):1664-9. PubMed ID: 8371164
[TBL] [Abstract][Full Text] [Related]
3. Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
Taguchi J; Abe J; Ohno M; Schwartz SM; Kurokawa K
Blood Press Suppl; 1994; 5():38-42. PubMed ID: 7889199
[TBL] [Abstract][Full Text] [Related]
4. Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Kai T; Horiuchi M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S360-2. PubMed ID: 9072428
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery.
Tazawa S; Nakane T; Chiba S
J Pharmacol Exp Ther; 1999 Feb; 288(2):898-904. PubMed ID: 9918604
[TBL] [Abstract][Full Text] [Related]
7. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
8. TCV-116 inhibits interstitial fibrosis and HSP47 mRNA in rat obstructive nephropathy.
Moriyama T; Kawada N; Akagi Y; Ando A; Horio M; Yamauchi A; Nagata K; Imai E; Hori M
Kidney Int Suppl; 1997 Dec; 63():S232-5. PubMed ID: 9407468
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension.
Ogihara T; Higashimori K; Masuo K; Mikami H
Clin Ther; 1993; 15(4):684-91. PubMed ID: 8221818
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of a novel nonpeptide angiotensin II subtype 1 receptor antagonist, TCV-116.
Nishikawa K; Inada Y; Shibouta Y; Wada T; Ojima M; Kubo K; Naka T
Blood Press Suppl; 1994; 5():7-14. PubMed ID: 7889205
[TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin system in hypertension in the elderly.
Nagano M; Higaki J; Mikami H; Ogihara T
Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
Kanno Y; Okada H; Suzuki H; Ikenaga H; Saruta T
Blood Press Suppl; 1994; 5():67-70. PubMed ID: 7889204
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog.
Miyazaki M; Shiota N; Sakonjo H; Takai S
Jpn J Pharmacol; 1999 Apr; 79(4):455-60. PubMed ID: 10361885
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
[TBL] [Abstract][Full Text] [Related]
15. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
16. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening.
Abe J; Deguchi J; Matsumoto T; Takuwa N; Noda M; Ohno M; Makuuchi M; Kurokawa K; Takuwa Y
Circulation; 1997 Sep; 96(6):1906-13. PubMed ID: 9323080
[TBL] [Abstract][Full Text] [Related]
17. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury.
Miyazaki M; Wada T; Shiota N; Takai S
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S21-5; discussion S33-4. PubMed ID: 10076917
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats.
Nagisa Y; Shintani A; Nakagawa S
Diabetologia; 2001 Jul; 44(7):883-8. PubMed ID: 11508274
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation.
Okada K; Bernstein ML; Zhang W; Schuster DP; Botney MD
Am J Respir Crit Care Med; 1998 Sep; 158(3):939-50. PubMed ID: 9731029
[TBL] [Abstract][Full Text] [Related]
20. Effects of an angiotensin II receptor antagonist, TCV-116, on insulin sensitivity in fructose-fed rats.
Shimamoto K; Matsuda K; Takizawa H; Higashiura K; Ura N; Iimura O
Blood Press Suppl; 1994; 5():113-6. PubMed ID: 7889192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
